Anteotech (ADO) Short Interest
Anteotech (ASX:ADO) had 0.03% of shares reported as short positions as of 27 July 2026, representing 919,039 shares. Anteotech operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Anteotech
Anteotech Ltd specializes in the development and commercialization of advanced medical diagnostics and energy storage solutions, leveraging its proprietary nanotechnology platform. It operates in healthcare and energy sectors, aiming for a significant market position through innovative solutions such as its proprietary AnteoBind™ technology, which enhances the sensitivity and performance of diagnostic assays.
Short position
Anteotech (ASX:ADO) has 0.03% of its shares on issue reported as short positions as of 27 July 2026, or about 919,039 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has fallen 0.54 percentage points. Its highest recorded short interest was 0.56% in February 2026. ADO is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4ADO intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Anteotech
Latest ADO news
All news- The Pentagon backs silicon battery race as AnteoTech ramps up Ultranode
stockhead
- Updated Securities Trading Policy
asx
- Long Shortz with AnteoTech: Expanding life sciences opportunity after ADLM
stockhead
- AnteoTech continues to expand life sciences business pipeline as diagnostics push into US gathers pace
stockhead
- ADLM 2026 Expands Life Sciences Sales Pipeline
asx
About
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss ADO
Start a research thread or post the first pulse update